---
$id: https://graph.org.ai/products/commodity/51112007
$type: Product
source: UNSPSC
code: "51112007"
title: "Semaxanib"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Semaxanib

**UNSPSC Code**: 51112007
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular formula C15H14N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 71IA9S35AJ, chemically known as 3-((z)-(3,5-dimethylpyrrol-2-yl)methylene)-2-indolinone but generally known as semaxanib, which bears US NIH Compound Identifier 5329098. European Medicines Agency schedules Semaxanib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB32269. The term SEMAXANIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16., No. 1.2002, List 47). Most nations schedule semaxanib under HS 29337900 and SITC 51561. As of Q4 2014, SEMAXANIB remains the US FDA Preferred Term for this commodity. Semaxanib bears US NLM identifiers UMLS ID C1135174 and NCI Concept Code C1831. SMILES: O=C1NC2C(/C1=C/C1[NH]C(CC1C)C)CCCC2.

